Pearl Therapeutics
Develops a combination of products for the treatment of respiratory diseases, including chronic obstructive pulmonary disease. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$167—250m (Dealroom.co estimates Apr 2013.)
Redwood City California (HQ)
Authorizing premium user...